TNFRSF8 and anaplastic large cell lymphoma: Moreover, both studies documented a high degree of tolerability and safety in r/r HL and ALCL after CAR T-cell infusion18.Recently, Ramos et al. followed two parallel phase I/II studies involving patients with r/r HL and administered CD30 CAR T-cells.